| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $661,609 ) |
| | 2025 | 2025 | EXIMIUS DIAGNOSTICS CORP | 1917 MANNING AVE APT 4 | LOS ANGELES | CA | 90025-4877 | LOS ANGELES | USA | R44CA288163 | Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma | 000 | 3 | NIH | 8/22/2025 | $661,609 |
|
| Issue Date FY: 2024 ( Subtotal = $661,609 ) |
| | 2024 | 2024 | EXIMIUS DIAGNOSTICS CORP | 1917 MANNING AVE APT 4 | LOS ANGELES | CA | 90025-4877 | LOS ANGELES | USA | R44CA288163 | Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma | 001 | 2 | NIH | 9/9/2024 | $661,609 |
| | 2024 | 2023 | EXIMIUS DIAGNOSTICS CORP | 1917 MANNING AVE APT 4 | LOS ANGELES | CA | 90025-4877 | LOS ANGELES | USA | R44CA288163 | Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma | 000 | 1 | NIH | 8/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $661,609 ) |
| | 2023 | 2023 | EXIMIUS DIAGNOSTICS CORP | 1917 MANNING AVE | LOS ANGELES | CA | 90025-4877 | LOS ANGELES | USA | R44CA288163 | Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma | 000 | 1 | NIH | 9/14/2023 | $661,609 |
|
|
